228 related articles for article (PubMed ID: 32998311)
21. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
22. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells.
Lenggenhager D; Amrutkar M; Sántha P; Aasrum M; Löhr JM; Gladhaug IP; Verbeke CS
Cells; 2019 Jan; 8(1):. PubMed ID: 30621293
[TBL] [Abstract][Full Text] [Related]
23. Protonation of Piezo1 Impairs Cell-Matrix Interactions of Pancreatic Stellate Cells.
Kuntze A; Goetsch O; Fels B; Najder K; Unger A; Wilhelmi M; Sargin S; Schimmelpfennig S; Neumann I; Schwab A; Pethő Z
Front Physiol; 2020; 11():89. PubMed ID: 32116794
[TBL] [Abstract][Full Text] [Related]
24. Primary Cultures for Pancreatic Stellate Cells (PSCs).
Tian L; Lu Z; Miao Y
Methods Mol Biol; 2019; 1882():149-155. PubMed ID: 30378051
[TBL] [Abstract][Full Text] [Related]
25. MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Li C; Morvaridi S; Lam G; Chheda C; Kamata Y; Katsumata M; Edderkaoui M; Yuan X; Nissen N; Pandol SJ; Wang Q
Front Physiol; 2019; 10():147. PubMed ID: 30863319
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models.
Che PP; Gregori A; Firuzi O; Dahele M; Sminia P; Peters GJ; Giovannetti E
Exp Hematol Oncol; 2020; 9():18. PubMed ID: 32775041
[TBL] [Abstract][Full Text] [Related]
27. IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth.
Li J; Wu X; Schiffmann L; MacVicar T; Zhou C; Wang Z; Li D; Camacho OV; Heuchel R; Odenthal M; Hillmer A; Quaas A; Zhao Y; Bruns CJ; Popp FC
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771503
[TBL] [Abstract][Full Text] [Related]
28. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
Saison-Ridinger M; DelGiorno KE; Zhang T; Kraus A; French R; Jaquish D; Tsui C; Erikson G; Spike BT; Shokhirev MN; Liddle C; Yu RT; Downes M; Evans RM; Saghatelian A; Lowy AM; Wahl GM
PLoS One; 2017; 12(12):e0189051. PubMed ID: 29211796
[TBL] [Abstract][Full Text] [Related]
29. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression.
Wilson JS; Pirola RC; Apte MV
Front Physiol; 2014; 5():52. PubMed ID: 24592240
[TBL] [Abstract][Full Text] [Related]
30. Functions of pancreatic stellate cell-derived soluble factors in the microenvironment of pancreatic ductal carcinoma.
Wu Q; Tian Y; Zhang J; Zhang H; Gu F; Lu Y; Zou S; Chen Y; Sun P; Xu M; Sun X; Xia C; Chi H; Ying Zhu A; Tang D; Wang D
Oncotarget; 2017 Nov; 8(60):102721-102738. PubMed ID: 29254283
[TBL] [Abstract][Full Text] [Related]
31. Ion channels in control of pancreatic stellate cell migration.
Storck H; Hild B; Schimmelpfennig S; Sargin S; Nielsen N; Zaccagnino A; Budde T; Novak I; Kalthoff H; Schwab A
Oncotarget; 2017 Jan; 8(1):769-784. PubMed ID: 27903970
[TBL] [Abstract][Full Text] [Related]
32. How fibrosis influences imaging and surgical decisions in pancreatic cancer.
Erkan M; Hausmann S; Michalski CW; Schlitter AM; Fingerle AA; Dobritz M; Friess H; Kleeff J
Front Physiol; 2012; 3():389. PubMed ID: 23060813
[TBL] [Abstract][Full Text] [Related]
33. Isolation and culture of primary human pancreatic stellate cells that reflect the context of their tissue of origin.
Strobel O; Dadabaeva N; Felix K; Hackert T; Giese NA; Jesenofsky R; Werner J
Langenbecks Arch Surg; 2016 Feb; 401(1):89-97. PubMed ID: 26712717
[TBL] [Abstract][Full Text] [Related]
34. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis.
Perera CJ; Falasca M; Chari ST; Greenfield JR; Xu Z; Pirola RC; Wilson JS; Apte MV
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680372
[TBL] [Abstract][Full Text] [Related]
35. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
[TBL] [Abstract][Full Text] [Related]
36. Identification of key pathways and gene changes in primary pancreatic stellate cells after cross-talk with pancreatic cancer cells (BXPC-3) using bioinformatics analysis.
Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
Neoplasma; 2019 May; 66(3):446-458. PubMed ID: 30784291
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic cancer: The microenvironment needs attention too!
Apte MV; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS
Pancreatology; 2015 Jul; 15(4 Suppl):S32-8. PubMed ID: 25845856
[TBL] [Abstract][Full Text] [Related]
38. BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.
Kumar K; DeCant BT; Grippo PJ; Hwang RF; Bentrem DJ; Ebine K; Munshi HG
JCI Insight; 2017 Feb; 2(3):e88032. PubMed ID: 28194432
[TBL] [Abstract][Full Text] [Related]
39. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.
Chen ST; Kuo TC; Liao YY; Lin MC; Tien YW; Huang MC
Oncogene; 2018 Nov; 37(46):6041-6053. PubMed ID: 29993037
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer.
Masamune A; Shimosegawa T
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1():S98-103. PubMed ID: 26189983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
